KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Jazz Pharmaceuticals (JAZZ) Debt Ratio: 2010-2025

Historic Debt Ratio for Jazz Pharmaceuticals (JAZZ) over the last 14 years, with Sep 2025 value amounting to 0.47.

  • Jazz Pharmaceuticals' Debt Ratio fell 5.34% to 0.47 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.47, marking a year-over-year decrease of 5.34%. This contributed to the annual value of 0.51 for FY2024, which is 1.42% up from last year.
  • As of Q3 2025, Jazz Pharmaceuticals' Debt Ratio stood at 0.47, which was down 3.68% from 0.49 recorded in Q2 2025.
  • Jazz Pharmaceuticals' Debt Ratio's 5-year high stood at 0.55 during Q3 2022, with a 5-year trough of 0.31 in Q1 2021.
  • Moreover, its 3-year median value for Debt Ratio was 0.50 (2024), whereas its average is 0.50.
  • Its Debt Ratio has fluctuated over the past 5 years, first soared by 64.55% in 2022, then decreased by 7.70% in 2025.
  • Over the past 5 years, Jazz Pharmaceuticals' Debt Ratio (Quarterly) stood at 0.49 in 2021, then rose by 7.40% to 0.53 in 2022, then dropped by 5.09% to 0.50 in 2023, then rose by 1.42% to 0.51 in 2024, then dropped by 5.34% to 0.47 in 2025.
  • Its Debt Ratio stands at 0.47 for Q3 2025, versus 0.49 for Q2 2025 and 0.47 for Q1 2025.